OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Predictive and Prognostic Role of Pre-Therapy and Interim 68Ga-DOTATOC PET/CT Parameters in Metastatic Advanced Neuroendocrine Tumor Patients Treated with PRRT
Rexhep Durmo, Angelina Filice, Federica Fioroni, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 592-592
Open Access | Times Cited: 18
Rexhep Durmo, Angelina Filice, Federica Fioroni, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 592-592
Open Access | Times Cited: 18
Showing 18 citing articles:
Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update
Martina Di Franco, Lucia Zanoni, Emilia Fortunati, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 5, pp. 538-550
Open Access | Times Cited: 8
Martina Di Franco, Lucia Zanoni, Emilia Fortunati, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 5, pp. 538-550
Open Access | Times Cited: 8
Models using comprehensive, lesion-level, longitudinal [68Ga]Ga-DOTA-TATE PET-derived features lead to superior outcome prediction in neuroendocrine tumor patients treated with [177Lu]Lu-DOTA-TATE
Victor Santoro-Fernandes, Brayden Schott, Alison Deatsch, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 11, pp. 3428-3439
Closed Access | Times Cited: 5
Victor Santoro-Fernandes, Brayden Schott, Alison Deatsch, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 11, pp. 3428-3439
Closed Access | Times Cited: 5
Long-term prognostic factors for PRRT in neuroendocrine tumors
Nils F. Trautwein, Johannes Schwenck, Johann Jacoby, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 11
Nils F. Trautwein, Johannes Schwenck, Johann Jacoby, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 11
Molecular Imaging for Response Assessment of Neuroendocrine Tumors (NET)
Martina Di Franco, Giuseppe Lamberti, Davide Campana, et al.
Seminars in Nuclear Medicine (2025)
Open Access
Martina Di Franco, Giuseppe Lamberti, Davide Campana, et al.
Seminars in Nuclear Medicine (2025)
Open Access
Somatostatin Receptor Targeted PET-Imaging for Diagnosis, Radiotherapy Planning and Theranostics of Meningiomas: A Systematic Review of the Literature
Luca Filippi, Isabella Palumbo, Oreste Bagni, et al.
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1666-1666
Open Access | Times Cited: 15
Luca Filippi, Isabella Palumbo, Oreste Bagni, et al.
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1666-1666
Open Access | Times Cited: 15
Prognostic Implications of PET-Derived Tumor Volume and Uptake in Patients with Neuroendocrine Tumors
Manuel Weber, Tuğçe Telli, David Kersting, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3581-3581
Open Access | Times Cited: 6
Manuel Weber, Tuğçe Telli, David Kersting, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3581-3581
Open Access | Times Cited: 6
Prediction of 177Lu-DOTATATE Therapy Outcomes in Neuroendocrine Tumor Patients Using Semi-Automatic Tumor Delineation on 68Ga-DOTATATE PET/CT
Hwan Lee, Sarit T. Kipnis, Remy Niman, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 200-200
Open Access | Times Cited: 6
Hwan Lee, Sarit T. Kipnis, Remy Niman, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 200-200
Open Access | Times Cited: 6
Prognostic value of interim [68Ga]Ga-DOTA-TOC PET/CT in patients with neuroendocrine tumour who underwent peptide receptor radionuclide therapy
Eonwoo Shin, Yong-il Kim, Changhoon Yoo, et al.
European Radiology (2024)
Closed Access | Times Cited: 2
Eonwoo Shin, Yong-il Kim, Changhoon Yoo, et al.
European Radiology (2024)
Closed Access | Times Cited: 2
Gastroenteropancreatic Neuroendocrine Tumor Diagnosis
Asha Kandathil, Rathan M. Subramaniam
PET Clinics (2022) Vol. 18, Iss. 2, pp. 189-200
Closed Access | Times Cited: 9
Asha Kandathil, Rathan M. Subramaniam
PET Clinics (2022) Vol. 18, Iss. 2, pp. 189-200
Closed Access | Times Cited: 9
Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT
Luca Urso, Angelo Castello, Giorgio Treglia, et al.
Diagnostics (2023) Vol. 13, Iss. 4, pp. 606-606
Open Access | Times Cited: 4
Luca Urso, Angelo Castello, Giorgio Treglia, et al.
Diagnostics (2023) Vol. 13, Iss. 4, pp. 606-606
Open Access | Times Cited: 4
Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs
Jonathan M. Loree, David Chan, Jennifer Lim, et al.
JAMA Oncology (2024)
Closed Access | Times Cited: 1
Jonathan M. Loree, David Chan, Jennifer Lim, et al.
JAMA Oncology (2024)
Closed Access | Times Cited: 1
Neuroendocrine Tumor Therapy Response Assessment
Vetri Sudar Jayaprakasam, Lisa Bodei
PET Clinics (2023) Vol. 18, Iss. 2, pp. 267-286
Closed Access | Times Cited: 3
Vetri Sudar Jayaprakasam, Lisa Bodei
PET Clinics (2023) Vol. 18, Iss. 2, pp. 267-286
Closed Access | Times Cited: 3
Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy
Þorvarður R. Hálfdánarson, Nadine Mallak, Scott Paulson, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4836-4836
Open Access | Times Cited: 3
Þorvarður R. Hálfdánarson, Nadine Mallak, Scott Paulson, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4836-4836
Open Access | Times Cited: 3
Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade
Taymeyah Al‐Toubah, Jonathan Strosberg, Julie Hallanger‐Johnson, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 3
Taymeyah Al‐Toubah, Jonathan Strosberg, Julie Hallanger‐Johnson, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 3
Theranostics in Neuroendocrine Tumors: Updates and Emerging Technologies
Nadine Mallak, Burçak Yılmaz, Catherine Meyer, et al.
Current Problems in Cancer (2024) Vol. 52, pp. 101129-101129
Closed Access
Nadine Mallak, Burçak Yılmaz, Catherine Meyer, et al.
Current Problems in Cancer (2024) Vol. 52, pp. 101129-101129
Closed Access
Endocrine and Neuroendocrine Tumors: A Special Issue
Alfredo Berruti, Vito Amoroso, Nicola Fazio
Cancers (2022) Vol. 14, Iss. 20, pp. 4994-4994
Open Access | Times Cited: 1
Alfredo Berruti, Vito Amoroso, Nicola Fazio
Cancers (2022) Vol. 14, Iss. 20, pp. 4994-4994
Open Access | Times Cited: 1
Prognostic Value of Somatostatin Receptor-Derived Volumetric Parameters from a Hybrid Standardized Uptake Value Thresholding Method in Patients with 68Ga-DOTATATE-Avid Stage IV Neuroendocrine Neoplasms: A Preliminary Study
Zhaoting Cheng, Sijuan Zou, Jianyuan Zhou, et al.
Neuroendocrinology (2023) Vol. 114, Iss. 9, pp. 805-815
Closed Access
Zhaoting Cheng, Sijuan Zou, Jianyuan Zhou, et al.
Neuroendocrinology (2023) Vol. 114, Iss. 9, pp. 805-815
Closed Access
